Pembrolizumab Associated Bilateral Optic Neuritis: A Case Report

A 52-year-old female patient on pembrolizumab for vulvar squamous cell carcinoma developed bilateral optic neuritis. The case report, authored by Robert Finley and licensed under CC-BY-4.0, details management with plasmapheresis after non-response to intravenous steroids. It was last updated on May 20, 2026.

Use Cases

• Illustrating a rare vision-threatening side effect based on the described case of pembrolizumab-induced optic neuritis.
• Studying treatment efficacy for immune-related adverse events based on the described use of plasmapheresis.
• Educating on differential diagnosis in cancer patients with vision loss based on the discussion of drug-induced neuropathy versus metastasis.

Strengths

• The dataset is licensed under CC-BY-4.0, permitting broad reuse.
• It focuses on a specific and documented rare adverse event.

Limitations

• The dataset consists of 1.7 MB of PNG and JPG files, suggesting it is likely a small collection of images from a single case report.
• Row count and column-level documentation are unknown, limiting suitability assessment.
• The data is from a single case, which may not be generalizable.

Provenance

Source

figshare

Collection Method

Case report.

Freshness

Last updated 2026-05-20 07:53:13; freshness should be verified.